This research offers further insight into this emerging safety signal, according to the study authors who noted in their Ophthalmology paper, Our novel, stratified analysis provides a more nuanced interpretation than previous pooled reviews, isolating a potential increased risk signal to observational data in the diabetes population only, a finding not corroborated by RCTs. These results are somewhat at odds with the narrative surrounding GLP-1 use and NAION risk that began in early 2024, but the researchers say they are confident in their methodology
WHITE PLAINS, NEW YORK JANUARY 13, 2009 A report by ConsumerLab.com on supplements containing the anti-oxidant CoQ10 shows the difficulty for consumers in determining an appropriate dosage
Effects of semaglutide on weight loss, body composition, and hormonal and metabolic markers in women with PCOS
They are a combination of natural compounds that may (not proven) promote weight loss
There have not been studies done on the effects of supplements on kidney disease though
Side effects are rare but may include mild pain or redness at the injection site
